Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32+0.47 (+54.71%)
Close on Nov 19, 2026Market cap $22.01MP/E –Yield –
Marker Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Marker Therapeutics's free cash flow for the twelve months ending Mar 31, 2020 was -$18.75M. For fiscal 2019 it was -$18.66M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$18.66M | – |
| FY2018 | Dec 31, 2018 | -$14.63M | – |
| FY2017 | Dec 31, 2017 | -$8.44M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | -$4.20M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.57M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.72M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.26M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.10M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.40M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.35M | – |
See a number that looks wrong?